Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123142762 | 12314276 | 2 | F | 20160708 | 20160428 | 20160712 | EXP | FR-PFIZER INC-2015275458 | PFIZER | CURIS, E.. PHARMACOKINETIC VARIABILITY OF CLINDAMYCIN AND INFLUENCE OF RIFAMPICIN ON CLINDAMYCIN CONCENTRATION IN PATIENTS WITH BONE AND JOINT INFECTIONS. INFECTION. 2015;43(4):473-481 | 62.00 | YR | M | Y | 133.00000 | KG | 20160712 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123142762 | 12314276 | 1 | PS | CLINDAMYCIN PHOSPHATE. | CLINDAMYCIN PHOSPHATE | 1 | UNK | U | 50441 | ||||||||||
| 123142762 | 12314276 | 2 | C | PEFLOXACIN | PEFLOXACIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123142762 | 12314276 | 1 | Staphylococcal infection |
| 123142762 | 12314276 | 2 | Staphylococcal infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123142762 | 12314276 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123142762 | 12314276 | Antibiotic level below therapeutic | |
| 123142762 | 12314276 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |